Development new radiopharmaceutical based on 5-thio-d- glucose labeled technetium-99m; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine

מידע ביבליוגרפי
Parent link:IOP Conference Series: Materials Science and Engineering
Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine.— 2016.— [012044, 6 p.]
מחבר תאגידי: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)
מחברים אחרים: Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Skuridin V. S. Viktor Sergeyevich, Ilina E. S. Elena Sergeevna, Rogov A. S. Alexander Sergeyevich, Nesterov E. A. Evgeny Alexandrovich, Sadkin V. L. Vladimir Leonidovich, Larionova L. A. Lyudmila Aleksandrovna, Varlamova N. V. Natalya Valeryevna, Zelchan (Zeltchan) R. V. Roman Vladimirovich
סיכום:Title screen
The article considers the obtaining and possibility of using 5-thio-D-glucose labeled technetium-99m for the diagnosis of malignant tumors by single photon emission computed tomography. The analysis of the level of international developments of radiopharmaceuticals based on derivatives of glucose has been carried out. Also the article provides information on of using experimental batches of lyophilisate on the basis of 5-thio-D-glucose for preliminary biomedical testing on the mice.
שפה:אנגלית
יצא לאור: 2016
נושאים:
גישה מקוונת:http://dx.doi.org/10.1088/1757-899X/135/1/012044
http://earchive.tpu.ru/handle/11683/34834
פורמט: אלקטרוני Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=650330

פריטים דומים